XinnuoPharma

About XinnuoPharma

Jinan Xinnuo Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the research, development, and production of advanced pharmaceutical intermediates and active pharmaceutical ingredients (APIs).

We are committed to drug synthesis in the fields of gout fatigue, nutrition, cancer, anti-depression, anti-Alzheimer's disease, and cardiovascular and cerebrovascular diseases. Our mission is to let more people enjoy healthy happiness through innovation and quality.

Integrated R&D, Production & Export
Advanced Detection & Synthesis Technology
Incubator of Jinan Pharmaceutical Valley

Our Product Portfolio

We offer over 300 high-purity pharmaceutical intermediates and APIs, serving global markets in Southeast Asia, South America, and Eastern Europe.

Thioacetamide

CAS-like compound used in pharmaceutical synthesis and analytical reagents.

Intermediate

4-Hydroxythiobenzamide

Key intermediate in heterocyclic drug development with antioxidant properties.

Intermediate

Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate

Building block for thiazole-based anti-inflammatory and anticancer agents.

Intermediate

Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate

Aldehyde-functionalized intermediate for Schiff base formation in CNS drug design.

Intermediate

7β-Amino-3-[4-pyridyl-2-thiazole sulfur radical]-3-cephem-4-carboxylic acid ·2HCl

Cephalosporin derivative with broad-spectrum antibacterial potential.

API

C29H25Cl2N4O3S3

Complex heterocyclic compound with dual-action pharmacophore for targeted therapy.

Research Product

5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]-7-pyrimidinone

PDE5 inhibitor analog with potential cardiovascular and erectile dysfunction applications.

API

2-Chloromethyl-4-methoxy-3-methylpyridine Hydrochloride

Key intermediate in proton pump inhibitor (PPI) synthesis such as omeprazole analogs.

Intermediate

Pyrimidin-2-ylmethanamine hydrochloride

Amino-functionalized pyrimidine for nucleoside analogs and kinase inhibitors.

Intermediate

3-(Bromoacetyl)-5-chloro-2-thiophenesulfonamide

Sulfonamide-based compound with potential diuretic and carbonic anhydrase inhibition.

Intermediate

(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide

Chiral thienothiazine derivative with COX-2 inhibition potential.

Research Product

5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one

Sulfonyl-modified PDE5 inhibitor with enhanced solubility and bioavailability.

API

View Full Product Catalog

R&D & Production Strength

Backed by a complete quality assurance system and strong scientific research capabilities, XinnuoPharma launches high-tech, market-driven synthetic drugs every year.

Research & Development

Our R&D team focuses on innovative synthesis routes, process optimization, and novel molecule design. We maintain strict compliance with international standards and invest heavily in analytical instrumentation and lab automation.

In-house synthesis and purification labs
HPLC, GC-MS, NMR, FTIR for QC
Annual launch of new high-tech products
Collaboration with academic and industrial partners

Advanced Production System

As an integrated enterprise combining R&D, production, and export trade, we operate state-of-the-art facilities with exquisite synthetic technology and advanced detection methods.

GMP-compliant manufacturing processes
Scalable batch and continuous flow systems
Full traceability and documentation
Export-ready packaging and regulatory support

Latest News

Stay updated with company developments and industry insights.

Company News

Expansion of API Production Line

XinnuoPharma announces the successful scale-up of its PDE5 inhibitor API line to meet growing international demand.

Industry Information

Trends in CNS Drug Development

Insights into the growing need for novel anti-depression and anti-Alzheimer’s compounds in aging populations.

China Quality Suppliers fobcompany.info

Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.

For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.

如果您是域名所有者不想被fobcompany.info收录请用企业邮箱联系[email protected] 取消收录我们将在3个工作日取消您的收录

Service Request: If you are other domain and want to be included, please contact [email protected]

如果您是其他域名合作也请联系[email protected]

About XinnuoPharma

Our Product Portfolio

Thioacetamide

4-Hydroxythiobenzamide

Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate

Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate

7β-Amino-3-[4-pyridyl-2-thiazole sulfur radical]-3-cephem-4-carboxylic acid ·2HCl

C29H25Cl2N4O3S3

5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]-7-pyrimidinone

2-Chloromethyl-4-methoxy-3-methylpyridine Hydrochloride

Pyrimidin-2-ylmethanamine hydrochloride

3-(Bromoacetyl)-5-chloro-2-thiophenesulfonamide

(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide

5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one

R&D & Production Strength

Research & Development

Advanced Production System

Latest News

Expansion of API Production Line

Trends in CNS Drug Development

Get in Touch

Contact Information